![](/img/cover-not-exists.png)
A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer
Beg, Muhammad S., Azad, Nilofer S., Patel, Sandip P., Torrealba, Jose, Mavroukakis, Sharon, Beatson, Melony A., Wang, Xue Ping, Arlen, Philip M., Morse, Michael A.Volume:
78
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3108-5
Date:
September, 2016
File:
PDF, 712 KB
english, 2016